期刊文献+

甲氧基喜树碱纳米粒子的制备及其体外释放研究 被引量:1

Preparation and Characterization of Controlled-release Formulations for Methoxycamptothecin Nanoparticles
下载PDF
导出
摘要 采用乳化溶剂挥发的方法制备MeOCPT纳米粒子,结果表明:MeOCPT纳米粒子具有明显的圆形结构,且表面光滑,大小均匀,粒度分布在100~300nm之间。MeOCPT的栽药量和包封率分别为(3.10±1.19)%和(83.57±3.45)%,在体外可以持续缓慢释放,累积释放率接近60%,达到了预期的药物缓慢释放及降低毒性的结果。 The nanoparticles contained MeOCPT prepared with the method emulsion and solvent evaporation.The MeOCPT nanoparticles had a circular structure,with a smooth surface ,uniform size, and its particle size distributed between 100 nm and 300 nm.The drug-loading rate and entrapment efficiency of MeOCPT nanoparticles were (3.10± 1.19 )% and (83.57±3.45)%.MeOCPT nanoparticles released slowly and lastingly in vitro whose cumulative release rate was nearly 60%,which could release the drugs slowly and reduce the toxicity of drugs.
出处 《现代农业科技》 2015年第8期173-173,179,共2页 Modern Agricultural Science and Technology
关键词 甲氧基喜树碱 聚乳酸 纳米粒子 体外释放 Methoxycamptothecin polylactic acid nanoparticles in vitro drug release
  • 相关文献

参考文献5

  • 1LIU Zhen-fengWANG Guo-lin, DONG Meng-jie, et al.Simple automatedradiosynthesis of 10-[ 11C]methoxy-20 (S)-camptothecin and biodistri- bution in normal mice[J].Appl Radiat Isot, 2012,70 ( 10 ) : 2516-2524.
  • 2JOSEPH F P, LEONARD B S.The camptothecins[J].New drug classes, 2003 (361 ) : 2235-2242.
  • 3蔡俊超,冯大为,殷盂光,等.dl-10-羟基喜树碱及dl-10-甲氧基喜树碱的全合成[J].化学学报,1981,39(2):171-176.
  • 4MORAWSKA-CHOCHOL A,DOMALIK-PYZ1K P.Gentamicin release from biodegradable poly-l-lactide based composites for novel intramed- ullary nails[J]. M at er Sci Eng C Mater Biol Appl, 2014 ( 45 ) : 15-20.
  • 5JEEVITHA D,MALATHY B R, BASKAR S K.Toxic effects of Aflatoxin B 1 on embryonic development of zebrafish (Danio rerio) :Potential activity of Piceatannol encapsulated Chitosan/poly (lactic acid )nanoparticles[J]. Anticancer Agents Med Chem, 2014,15 (2) : 248-257.

同被引文献15

  • 1段友容,张志荣,唐永刚.PELGE纳米粒的制备及影响粒径大小的因素[J].四川大学学报(医学版),2005,36(1):115-118. 被引量:6
  • 2Wall ME,Wani MC,Cook CE,et al.Plant antitumor agents.I.The isolation and structure of camptothecin,a novel alka- loidal leukemia and tumor inhibitor from Camptotheca acumi- nata.J Am Chem Soc,1966,88:3888-3890.
  • 3Liehr JG,Harris NJ,Mendoza J,et al.Pharmacology of camp- tothecin esters.Ann NY Acad Sci,2000,922:216-223.
  • 4Zhang R (张瑞).Preparation and characterization of con- trolled-release formulations for methoxycamptothecin nanop- articles.Haerbin:Northeast Forestry University(东北林业大学),PhD.2013.
  • 5Lin LZ(林隆泽),Zhao ZY(赵志远),Xu RS(徐任生).Chemical constituents of the anticancer plant Camptotheca acuminata Decne.化学学报,1977,35;227-231.
  • 6Zheng J (郑健).Pharmacokinetic studies of 10-methoxy- camptothecin in rats.Harbin:Northeast Forestry University(东北林业大学),PhD.:2013,.
  • 7Sanchez A,Tobio M,Gonzalez L,et al.Biodegradable micro- and nanoparticles as long-term delivery vehicles for interfer- on-alpha.Eur J Pharm Sci,2003,18:221-229.
  • 8Murakami H,Kobayashi M,Takeuchi H,et al.Further appli- cation of a modified spontaneous emulsification solvent diffu- sion method to various types of PLGA and PLA polymers for preparation of nanoparticles.Power Technol,2000,107:137-143.
  • 9Dong Y,Feng S.Methoxy poly ( ethylene glycol) -poly (lac- tide) nanoparticles for controlled delivery of anticancer drugs.Biomaterials,2004,25:2843-2849.
  • 10杨小玲,王珊,孟小华.新型共聚物淀粉接技聚乳酸的制备及其表征[J].天然产物研究与开发,2009,21(6):1036-1038. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部